XETRA · Healthcare
Invest in Coloplast stock from India
Indian and foreign residents can buy Coloplast (CBHD) shares directly through Paasa.
By Paasa · Updated
Coloplast at a glance
- Price
- €55.68-€0.30 (0.54%)
- Market cap
- €12.55B
- Day range
- €55.68 – €56.44
- P/E
- 34.09
- Dividend yield
- 5.50%
- Volume
- 251.00
- 1 month
- -9.96%
- 6 months
- -4.95%
- YTD
- -23.79%
- 1 year
- -23.77%
- 5 years
- -59.51%
Coloplast statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | DKK 27.8B | DKK 27.0B | DKK 24.5B | DKK 22.6B | DKK 19.4B |
| Gross profit | DKK 18.1B | DKK 18.3B | DKK 16.3B | DKK 15.5B | DKK 13.3B |
| Operating income | DKK 7.6B | DKK 7.3B | DKK 6.8B | DKK 6.4B | DKK 6.4B |
| Net income | DKK 3.6B | DKK 5.1B | DKK 4.8B | DKK 4.7B | DKK 4.8B |
| Earnings per share | DKK 16.09 | DKK 22.46 | DKK 22.20 | DKK 22.14 | DKK 22.67 |
| EBITDA | DKK 8.3B | DKK 8.5B | DKK 7.7B | DKK 7.2B | DKK 7.0B |
| Total assets | DKK 48.2B | DKK 48.1B | DKK 48.2B | DKK 35.0B | DKK 15.8B |
| Total debt | DKK 22.6B | DKK 22.6B | DKK 19.6B | DKK 18.7B | DKK 2.8B |
| Cash and short-term investments | DKK 944.7M | DKK 788.0M | DKK 911.0M | DKK 633.0M | DKK 674.0M |
| Shareholders' equity | DKK 16.1B | DKK 17.9B | DKK 17.3B | DKK 8.3B | DKK 8.2B |
| Operating cash flow | DKK 6.6B | DKK 2.8B | DKK 4.2B | DKK 5.1B | DKK 5.3B |
| Free cash flow | DKK 5.3B | DKK 1.4B | DKK 3.0B | DKK 4.0B | DKK 3.3B |
| Capital expenditure | −DKK 1.3B | −DKK 1.3B | −DKK 1.2B | −DKK 1.1B | −DKK 2.0B |
Fiscal years as reported, the latest ending 30 Sep 2025. Figures in DKK; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| Fresenius SE & Co. KGaA | FRE.DE | €44.91 | €25.29B |
| Biogen | IDP.DE | €165.68 | €24.48B |
| BioNTech | 22UA.F | €86.05 | €21.62B |
| Koninklijke Philips | PHI1.DE | €21.55 | €21.06B |
| Genmab | GE9.F | €312.70 | €19.23B |
| Illumina | ILU.DE | €124.28 | €18.80B |
| Sartorius | SRT3.DE | €258.30 | €17.84B |
| Sartorius | SRT.DE | €207.00 | €14.29B |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in Coloplast from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search CBHD and buy
Find Coloplast by name or by its ticker, CBHD, and place your order.
Why invest in Coloplast from India
What Coloplast does
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. Coloplast operates in the Medical - Instruments & Supplies industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Coloplast stock from India?
Yes. Indian residents and NRIs can buy Coloplast (CBHD) shares directly through Paasa. Coloplast is listed on XETRA, in the Medical - Instruments & Supplies industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
How are Coloplast dividends taxed for Indian investors?
Coloplast trades on XETRA but is domiciled in Denmark, so any withholding on its dividends follows that country's rules rather than those of Germany. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Coloplast shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.